StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Modulight Oyj
Helsinki Stock Exchange:MODU.HE
Sector
Location
Market Cap
USD 63.81 M
Share Price
USD 1.51
Avg Daily Volume
19,267
Change (1 day)
0.91%
Change (1 year)
21.19%
Change (YTD)
59.42%
Modulight Oyj Revenue for the year ending December 31, 2024: USD 4.24 M
Modulight Oyj Revenue is USD 4.24 M for the year ending December 31, 2024, a -4.55% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Modulight Oyj Revenue for the year ending December 31, 2023 was USD 4.44 M, a -9.72% change year over year.
-
Modulight Oyj Revenue for the year ending December 31, 2022 was USD 4.92 M, a -52.35% change year over year.
-
Modulight Oyj Revenue for the year ending December 31, 2021 was USD 10.33 M, a -15.99% change year over year.
-
Modulight Oyj Revenue for the year ending December 31, 2020 was USD 12.29 M, a 52.29% change year over year.
Competitors
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.46
603392.SS
-0.14
-1.57%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Indegene Limited
USD 6.64
INDGN.NS
+0.01
0.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.46
603392.SS
-0.14
-1.57%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Indegene Limited
USD 6.64
INDGN.NS
+0.01
0.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%